89bio (ETNB) News Today $7.19 +0.39 (+5.74%) Closing price 04/2/2025 04:00 PM EasternExtended Trading$7.08 -0.11 (-1.46%) As of 07:06 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Pictet Asset Management Holding SA Sells 239,574 Shares of 89bio, Inc. (NASDAQ:ETNB)Pictet Asset Management Holding SA lowered its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 7.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,007,034 shaApril 2 at 4:31 AM | marketbeat.com89bio (NASDAQ:ETNB) Trading Down 8.8% - Should You Sell?89bio (NASDAQ:ETNB) Stock Price Down 8.8% - Should You Sell?April 1 at 2:00 PM | marketbeat.comRaymond James Financial Inc. Invests $2.95 Million in 89bio, Inc. (NASDAQ:ETNB)Raymond James Financial Inc. bought a new stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 377,370 shares of the company's stock, valued at approximately $2,951,000. RaMarch 30, 2025 | marketbeat.comETNB Crosses Above Key Moving Average LevelMarch 29, 2025 | nasdaq.com89bio (NASDAQ:ETNB) Trading Up 4.9% - Time to Buy?89bio (NASDAQ:ETNB) Stock Price Up 4.9% - Should You Buy?March 28, 2025 | marketbeat.com47,469 Shares in 89bio, Inc. (NASDAQ:ETNB) Acquired by BIT Capital GmbHBIT Capital GmbH acquired a new stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 47,469 shares of the company's stock, valued at approximately $371,000. SeveralMarch 28, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Shares Down 5.7% - Should You Sell?89bio (NASDAQ:ETNB) Stock Price Down 5.7% - Here's What HappenedMarch 26, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Receives "Sell (D-)" Rating from Weiss RatingsMarch 24, 2025 | americanbankingnews.com89bio (NASDAQ:ETNB) Given Sell (D-) Rating at Weiss RatingsWeiss Ratings reiterated a "sell (d-)" rating on shares of 89bio in a report on Saturday.March 24, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Given Average Rating of "Moderate Buy" by Brokerages89bio, Inc. (NASDAQ:ETNB - Get Free Report) has earned an average recommendation of "Moderate Buy" from the ten analysts that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one hasMarch 17, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Shares Sold by Steward Partners Investment Advisory LLCSteward Partners Investment Advisory LLC trimmed its holdings in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 74.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 20,210 shares of the compaMarch 17, 2025 | marketbeat.comGoldman Sachs Initiates Coverage of 89bio (ETNB) with Neutral RecommendationMarch 15, 2025 | msn.com89bio (NASDAQ:ETNB) Coverage Initiated by Analysts at The Goldman Sachs GroupThe Goldman Sachs Group initiated coverage on shares of 89bio in a research report on Friday. They set a "neutral" rating and a $11.00 price objective for the company.March 15, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Shares Gap Up - Time to Buy?89bio (NASDAQ:ETNB) Shares Gap Up - Here's WhyMarch 14, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Now Covered by CitigroupCitigroup assumed coverage on shares of 89bio in a research note on Thursday. They issued a "buy" rating and a $25.00 price target on the stock.March 14, 2025 | marketbeat.com89bio initiated with a Neutral at Goldman SachsMarch 14, 2025 | markets.businessinsider.com89bio (ETNB) Receives a New Rating from Goldman SachsMarch 14, 2025 | markets.businessinsider.com89bio initiated with a Buy at CitiMarch 13, 2025 | markets.businessinsider.comCitigroup Initiates Coverage of 89bio (ETNB) with Buy RecommendationMarch 13, 2025 | msn.com89bio (NASDAQ:ETNB) Stock Price Up 5.8% - What's Next?89bio (NASDAQ:ETNB) Trading 5.8% Higher - What's Next?March 13, 2025 | marketbeat.comBears are Losing Control Over 89BIO (ETNB), Here's Why It's a 'Buy' NowMarch 12, 2025 | msn.comCandriam S.C.A. Has $8.26 Million Stock Position in 89bio, Inc. (NASDAQ:ETNB)Candriam S.C.A. grew its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 24.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,055,661 shares of the company's stock after acquiring an additional 207,582 sMarch 8, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Earns Sell (D-) Rating from Weiss RatingsWeiss Ratings reissued a "sell (d-)" rating on shares of 89bio in a report on Friday.March 8, 2025 | marketbeat.comCantor Fitzgerald Forecasts Stronger Earnings for 89bio89bio, Inc. (NASDAQ:ETNB - Free Report) - Equities researchers at Cantor Fitzgerald upped their FY2025 earnings estimates for shares of 89bio in a research note issued on Tuesday, March 4th. Cantor Fitzgerald analyst K. Kluska now expects that the company will post earnings of ($1.88) per share fMarch 7, 2025 | marketbeat.comEvercore ISI Sticks to Its Buy Rating for 89bio (ETNB)March 6, 2025 | markets.businessinsider.comWhat is Leerink Partnrs' Estimate for 89bio FY2029 Earnings?89bio, Inc. (NASDAQ:ETNB - Free Report) - Equities research analysts at Leerink Partnrs upped their FY2029 earnings per share (EPS) estimates for 89bio in a note issued to investors on Friday, February 28th. Leerink Partnrs analyst T. Smith now anticipates that the company will earn $3.71 per shaMarch 3, 2025 | marketbeat.comBank of America Securities Keeps Their Buy Rating on 89bio (ETNB)March 2, 2025 | markets.businessinsider.comHC Wainwright Reiterates "Buy" Rating for 89bio (NASDAQ:ETNB)HC Wainwright reiterated a "buy" rating and set a $21.00 target price (down from $29.00) on shares of 89bio in a report on Friday.March 1, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Announces Earnings Results, Misses Estimates By $0.42 EPS89bio (NASDAQ:ETNB - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($1.02) earnings per share for the quarter, missing analysts' consensus estimates of ($0.60) by ($0.42).February 28, 2025 | marketbeat.com89bio price target lowered to $21 from $29 at H.C. WainwrightFebruary 28, 2025 | markets.businessinsider.com89bio reports Q4 EPS ($1.02), consensus (76c)February 27, 2025 | markets.businessinsider.com89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate UpdatesFebruary 27, 2025 | globenewswire.com89bio (ETNB) Projected to Post Earnings on Thursday89bio (NASDAQ:ETNB) will be releasing earnings before the market opens on Thursday, March 6, Financial Modeling Prep reports.February 27, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Shares Down 9.1% - What's Next?89bio (NASDAQ:ETNB) Shares Down 9.1% - Time to Sell?February 25, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Given Consensus Rating of "Moderate Buy" by BrokeragesShares of 89bio, Inc. (NASDAQ:ETNB - Get Free Report) have received an average recommendation of "Moderate Buy" from the nine brokerages that are currently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating anFebruary 20, 2025 | marketbeat.comWeiss Ratings Reiterates Sell (D-) Rating for 89bio (NASDAQ:ETNB)Weiss Ratings reiterated a "sell (d-)" rating on shares of 89bio in a research note on Wednesday.February 20, 2025 | marketbeat.comabrdn plc Cuts Stock Holdings in 89bio, Inc. (NASDAQ:ETNB)abrdn plc reduced its stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 30.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 329,338 shares of the company's stock after selling 141,049 shares during the period. abrdn plc owned approxFebruary 10, 2025 | marketbeat.comInsider Buying Surges in February, Especially in These 6 StocksFebruary 9, 2025 | 247wallst.comInstitutional investors have a lot riding on 89bio, Inc. (NASDAQ:ETNB) with 58% ownershipFebruary 6, 2025 | uk.finance.yahoo.com89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)February 6, 2025 | globenewswire.com89bio (NASDAQ:ETNB) Stock Price Up 7.1% - Here's What Happened89bio (NASDAQ:ETNB) Stock Price Up 7.1% - What's Next?February 5, 2025 | marketbeat.comWolfe Research Initiates Coverage of 89bio (ETNB) with Outperform RecommendationFebruary 5, 2025 | msn.comFY2024 Earnings Estimate for 89bio Issued By Leerink Partnrs89bio, Inc. (NASDAQ:ETNB - Free Report) - Analysts at Leerink Partnrs boosted their FY2024 earnings estimates for 89bio in a report issued on Sunday, February 2nd. Leerink Partnrs analyst T. Smith now expects that the company will earn ($2.97) per share for the year, up from their prior forecastFebruary 5, 2025 | marketbeat.comWolfe Research Initiates Coverage on 89bio (NASDAQ:ETNB)Wolfe Research started coverage on 89bio in a report on Tuesday. They issued an "outperform" rating for the company.February 4, 2025 | marketbeat.comFY2029 Earnings Forecast for 89bio Issued By Leerink Partnrs89bio, Inc. (NASDAQ:ETNB - Free Report) - Leerink Partnrs issued their FY2029 earnings estimates for shares of 89bio in a research note issued on Sunday, February 2nd. Leerink Partnrs analyst T. Smith anticipates that the company will earn $3.68 per share for the year. The consensus estimate forFebruary 4, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Director Acquires $49,999,993.75 in StockFebruary 4, 2025 | insidertrades.com89bio (NASDAQ:ETNB) Receives Sell (D-) Rating from Weiss RatingsWeiss Ratings reaffirmed a "sell (d-)" rating on shares of 89bio in a report on Saturday.February 4, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Short Interest Up 12.2% in January89bio, Inc. (NASDAQ:ETNB - Get Free Report) saw a significant growth in short interest in January. As of January 15th, there was short interest totalling 7,790,000 shares, a growth of 12.2% from the December 31st total of 6,940,000 shares. Based on an average daily trading volume, of 943,200 shares, the short-interest ratio is presently 8.3 days.February 4, 2025 | marketbeat.comRa Capital Management, L.P. Acquires 5,714,285 Shares of 89bio, Inc. (NASDAQ:ETNB) Stock89bio, Inc. (NASDAQ:ETNB - Get Free Report) Director Ra Capital Management, L.P. acquired 5,714,285 shares of the stock in a transaction dated Thursday, January 30th. The shares were bought at an average price of $8.75 per share, with a total value of $49,999,993.75. Following the completion of the transaction, the director now directly owns 19,554,319 shares of the company's stock, valued at $171,100,291.25. The trade was a 41.29 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.February 3, 2025 | marketbeat.com89bio Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesFebruary 3, 2025 | markets.businessinsider.com Remove Ads Get 89bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address ETNB Media Mentions By Week ETNB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETNB News Sentiment▼0.750.55▲Average Medical News Sentiment ETNB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETNB Articles This Week▼64▲ETNB Articles Average Week Remove Ads Get 89bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PTC Therapeutics News Zai Lab News Organon & Co. News Arcellx News Avidity Biosciences News Ultragenyx Pharmaceutical News Rhythm Pharmaceuticals News SpringWorks Therapeutics News Akero Therapeutics News Crinetics Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ETNB) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 89bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 89bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ETNB Stock Free ETNB Stock Alerts